Total Patients, n
|
16 |
|
Length of stay (days), median (IQR) |
3.8 |
(3.2–7.0) |
Clavien–Dindo complications < 30 days after surgery |
|
|
Total number, n (%) |
2 |
12.5% |
Grade II, n (%) |
2 |
12.5% |
Clavien–Dindo complications > 30 days after surgery |
|
|
Total number, n (%) |
3 |
18.7% |
Grade II, n (%) |
3 |
18.7% |
Total follow-up (months), median (IQR) |
34.5 |
(6–58) |
Postop Ureteral Diameter Affected Side (cm), median (IQR) |
0.7 |
(0.4–0.9) |
Postop Ipsilateral Renal Function (%), median (IQR) |
32.5 |
(14.8–47.5) |
Postop VUR on the affected side, n (%) |
1 |
(6.2%) |
Re-operation, n (%) |
1 |
(6.2%) |